Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles matching "immunodeficiency"

NewsUNITERAREApr 3

Fund Update: PAN Foundation — Primary immunodeficiency Fund Primary immunodeficiency fund is currently closed

The PAN Foundation's financial assistance program for people with primary immunodeficiency is currently closed and not accepting new applications. Primary immunodeficiency is a group of disorders where the immune system doesn't work properly, making it harder to fight infections. When this fund was open, it could help eligible patients pay up to $12,000 per year toward treatment costs.

WHY IT MATTERSPatients with primary immunodeficiency who were relying on this $12,000 annual assistance need to immediately identify alternative funding sources, as this program is no longer accepting applications as of April 2, 2026.
💬 Ask your doctorPrimary immunodeficiencyRead →
ResearchPUBMEDMar 26

Diagnostic odyssey of patients with the rare immunodeficiency activated PI3 kinase delta syndrome (APDS): case study from expert and patient surveys.

This study looked at how long it takes to diagnose APDS, a very rare immune system disorder that affects only 1-2 people per million. Researchers interviewed patients and doctors in Austria, Germany, and Switzerland and found that people typically wait several years before getting a correct diagnosis because the disease is so uncommon and looks different in different people.

WHY IT MATTERSPatients with APDS face years of diagnostic delay due to the disease's rarity and variable symptoms — understanding these barriers could help doctors recognize APDS faster and reduce the time families spend seeking answers.
💬 Ask your doctorActivated PI3 kinase delta syndrome (APDS)Primary immunodeficiencyRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases